Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Most cited article(s)

  • You have access
    To Scan or Not to Scan: An Unnecessary Dilemma for PSMA Radioligand Therapy
    Sandy Srinivas and Andrei Iagaru
    Journal of Nuclear Medicine November 1, 2021, 62 (11) 1487-1488; DOI: https://doi.org/10.2967/jnumed.121.263035
  • PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
    You have access
    PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
    Manuel Weber, Claudia Kurek, Francesco Barbato, Matthias Eiber, Tobias Maurer, Michael Nader, Boris Hadaschik, Viktor Grünwald, Ken Herrmann, Axel Wetter and Wolfgang P. Fendler
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 88-91; DOI: https://doi.org/10.2967/jnumed.120.245456
  • You have access
    The Future of Nuclear Medicine, Molecular Imaging, and Theranostics
    Wolfgang A. Weber, Johannes Czernin, Carolyn J. Anderson, Ramsey D. Badawi, Henryk Barthel, Frank Bengel, Lisa Bodei, Irène Buvat, Marcelo DiCarli, Michael M. Graham, Jan Grimm, Ken Herrmann, Lale Kostakoglu, Jason S. Lewis, David A. Mankoff, Todd E. Peterson, Heinrich Schelbert, Heiko Schöder, Barry A. Siegel and H. William Strauss
    Journal of Nuclear Medicine December 1, 2020, 61 (Supplement 2) 263S-272S; DOI: https://doi.org/10.2967/jnumed.120.254532
  • Impact of <sup>68</sup>Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
    You have access
    Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
    Manuel Röhrich, Patrick Naumann, Frederik L. Giesel, Peter L. Choyke, Fabian Staudinger, Annika Wefers, Dawn P. Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Matthias Lang and Stefan A. Koerber
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 779-786; DOI: https://doi.org/10.2967/jnumed.120.253062
  • You have access
    The Latest Developments in Imaging of Fibroblast Activation Protein
    Annette Altmann, Uwe Haberkorn and Jens Siveke
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 160-167; DOI: https://doi.org/10.2967/jnumed.120.244806
  • Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with <sup>177</sup>Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
    You have access
    Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
    Jeremie Calais, Andrei Gafita, Matthias Eiber, Wesley R. Armstrong, Jeannine Gartmann, Pan Thin, Kathleen Nguyen, Vincent Lok, Laura Gosa, Tristan Grogan, Rouzbeh Esfandiari, Martin Allen-Auerbach, Andrew Quon, Shadfar Bahri, Pawan Gupta, Linda Gardner, David Ranganathan, Roger Slavik, Magnus Dahlbom, Ken Herrmann, Ebrahim Delpassand, Wolfgang P. Fendler and Johannes Czernin
    Journal of Nuclear Medicine October 1, 2021, 62 (10) 1440-1446; DOI: https://doi.org/10.2967/jnumed.121.261982
  • You have access
    Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 2: The Role of Novel PET Agents
    Amir Iravani and Rodney J. Hicks
    Journal of Nuclear Medicine November 1, 2020, 61 (11) 1553-1559; DOI: https://doi.org/10.2967/jnumed.120.248823
  • You have access
    PSMA Expression Assessed by PET Imaging Is a Required Biomarker for Selecting Patients for Any PSMA-Targeted Therapy
    Jeremie Calais and Johannes Czernin
    Journal of Nuclear Medicine November 1, 2021, 62 (11) 1489-1491; DOI: https://doi.org/10.2967/jnumed.121.263159
  • You have access
    Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy
    Jonathan R. Strosberg, Taymeyah Al-Toubah, Eleonora Pellè, Johnna Smith, Mintallah Haider, Tai Hutchinson, Jason B. Fleming and Ghassan El-Haddad
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 69-72; DOI: https://doi.org/10.2967/jnumed.120.242875
  • You have access
    One-Stop Shop: 18F-Flortaucipir PET Differentiates Amyloid-Positive and -Negative Forms of Neurodegenerative Diseases
    Jochen Hammes, Gérard N. Bischof, Karl P. Bohn, Özgür Onur, Anja Schneider, Klaus Fliessbach, Merle C Hönig, Frank Jessen, Bernd Neumaier, Alexander Drzezga and Thilo van Eimeren
    Journal of Nuclear Medicine February 1, 2021, 62 (2) 240-246; DOI: https://doi.org/10.2967/jnumed.120.244061

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire